Edition:
United Kingdom

Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

32.31CAD
3:16pm GMT
Change (% chg)

$-1.01 (-3.03%)
Prev Close
$33.32
Open
$33.05
Day's High
$33.27
Day's Low
$31.99
Volume
196,539
Avg. Vol
925,354
52-wk High
$36.52
52-wk Low
$18.62

Select another date:

Tue, Oct 30 2018

Photo

Ex-Valeant, Philidor executives get prison for fraud

NEW YORK A former executive at Valeant Pharmaceuticals International Inc and the former head of a start-up mail-order pharmacy were sentenced to one year in prison on Tuesday after being convicted of defrauding the drugmaker through a secret kickback scheme.

UPDATE 1-Ex-Valeant, Philidor executives get prison for fraud

NEW YORK, Oct 30 A former executive at Valeant Pharmaceuticals International Inc and the former head of a start-up mail-order pharmacy were sentenced to one year in prison on Tuesday after being convicted of defrauding the drugmaker through a secret kickback scheme.

Ex-Valeant, Philidor executives get prison for fraud

NEW YORK, Oct 30 A former executive at Valeant Pharmaceuticals International Inc and the former head of a start-up mail-order pharmacy were sentenced to one year in prison on Tuesday after being convicted of defrauding the drugmaker through a secret kickback scheme.

Bausch Health's plaque psoriasis lotion gets tentative FDA approval

Bausch Health Cos Inc, formerly Valeant Pharmaceuticals, said on Monday it received tentative U.S. approval to market its plaque psoriasis lotion, Bryhali.

UPDATE 2-Bausch Health's plaque psoriasis lotion gets tentative FDA approval

Oct 8 Bausch Health Cos Inc , formerly Valeant Pharmaceuticals, said on Monday it received tentative U.S. approval to market its plaque psoriasis lotion, Bryhali.

Bausch Health's plaque psoriasis lotion gets tentative FDA approval

Oct 8 Bausch Health Cos said on Monday it received tentative approval from the U.S. health regulator to market its plaque psoriasis lotion, Bryhali.

Bausch Health unit moves to settle charges it misled investors -SEC

WASHINGTON Salix Pharmaceuticals, a unit of Bausch Health Companies Inc , has moved to settle charges brought by the U.S. Securities and Exchange Commission that it misled investors about the company's prospects, the SEC said on Friday.

UPDATE 3-Bausch Health unit moves to settle charges it misled investors -SEC

WASHINGTON, Sept 28 Salix Pharmaceuticals, a unit of Bausch Health Companies Inc, has moved to settle charges brought by the U.S. Securities and Exchange Commission that it misled investors about the company's prospects, the SEC said on Friday.

Bausch Health subsidiary moves to settle charges it misled investors -SEC

WASHINGTON, Sept 28 Salix Pharmaceuticals, a unit of Bausch Health Companies Inc, has moved to settle charges brought by the U.S. Securities and Exchange Commission that it misled investors about the company's prospects, the SEC said on Friday.

UPDATE 2-Bausch Health beats profit estimates, promises to cut debt

* Toronto shares rise 6 pct; New York shares 7.5 pct (Adds details from conference call, analyst comment, updates share price)

Select another date: